Market revenue in 2022 | USD 1,064.8 million |
Market revenue in 2030 | USD 2,938.1 million |
Growth rate | 13.5% (CAGR from 2022 to 2030) |
Largest segment | Kits & reagents |
Fastest growing segment | Enzymes |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Kits & Reagents, Enzymes |
Key market players worldwide | Thermo Fisher Scientific Inc, Illumina Inc, Agilent Technologies Inc, Qiagen NV, New England Biolabs, Merck KGaA, Roche Holding AG ADR, Bio-Rad Laboratories Inc, Takara Bio Inc, LGC Group, Bausch Health Companies Inc, Promega |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to molecular biology enzymes, reagents and kits market will help companies and investors design strategic landscapes.
Kits & reagents was the largest segment with a revenue share of 67.4% in 2022. Horizon Databook has segmented the China molecular biology enzymes, reagents and kits market based on kits & reagents, enzymes covering the revenue growth of each sub-segment from 2018 to 2030.
China is the fastest growing pharmaceutical market in the world. The country’s pharmaceutical market ranks second in the world. The country has emerged as a strategic player by establishing improved research and development facilities.
The expanding pharmaceutical industry in the country is expected to boost the molecular biology enzymes, kits, and reagents market in China. In addition, increasing investments from global pharmaceutical giants has expected to spur the market growth.
For instance, in November 2019, AstraZeneca launched an R&D center and AI Innovation Centre in Shanghai. The company has also partnered with China International Capital to create funds for the investment in Chinese healthcare startups.
Horizon Databook provides a detailed overview of country-level data and insights on the China molecular biology enzymes, reagents and kits market , including forecasts for subscribers. This country databook contains high-level insights into China molecular biology enzymes, reagents and kits market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account